Mirai Medical is a brand that specializes in providing safe and highly effective treatments for skin and gastrointestinal cancers. Their innovative ePORE® therapy utilizes precision cancer treatment technology to address critical unmet challenges in global cancer treatment. With the aim of preserving healthy tissue, ePORE® therapy specifically targets tumor tissue, resulting in minimal side effects and improved patient experiences.

This therapy can be performed as a day case procedure, reducing time spent in the hospital and offering a cost-effective alternative to traditional treatments. Mirai Medical's expertise in electroporation and therapeutic development is evident in their years of experience in the field. Their dedicated team of professionals includes Dr.

Declan Soden as the Founder and CEO, Colin Forde as the COO, Simon Ombler as the Sales and Marketing Director, and Seán Kinsella as the CTO. With a focus on precision and patient-centered care, Mirai Medical is at the forefront of advancing cancer treatment options